05.01.06
NutraCea, StoneBridge Pharma Sign Letter of Intent
NutraCea, El Dorado Hills, CA, has signed a binding letter of intent with StoneBridge Pharma, LLC, Duluth, GA, to market a line of over-the-counter (OTC) products under the RiceMucil name. The product line will target the human fiber market with a focus on a wide range of gastrointestinal disorders. The letter of intent states that StoneBridge, depending on the achievement of specific goals, including minimum sales volumes, will have the right to market the fiber products for seven years with an option to renew for additional three year periods.
NutraCea, El Dorado Hills, CA, has signed a binding letter of intent with StoneBridge Pharma, LLC, Duluth, GA, to market a line of over-the-counter (OTC) products under the RiceMucil name. The product line will target the human fiber market with a focus on a wide range of gastrointestinal disorders. The letter of intent states that StoneBridge, depending on the achievement of specific goals, including minimum sales volumes, will have the right to market the fiber products for seven years with an option to renew for additional three year periods.